Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

• Status: Recruiting
• Trial end date: 2022-12-01

Summary

To compare treatment with preservative-free dexamethasone 0.1% (Monofree Dexamethason) and diclofenac 0.1% (Dicloabak) eye drops versus preserved dexamethasone 0.1% (Maxidex) and diclofenac 0.1% (Voltaren Ophtha) eye drops after cataract surgery in terms of postoperative inflammation, iatrogenic dry eye disease and cystoid macular edema.

• Phase: Phase 4

Details

• Lead Sponsor: Universitaire Ziekenhuizen Leuven
• Collaborator: Laboratoires Thea
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate; Diclofenac; Ophthalmic Solutions